Mollard; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mollard; Paul.The latest application filed is for "polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide".

Company Profile

11.28.30

Mollard; Paul - Mountain View CA
Mollard; Paul - Saratoga CA
- Saratoga CA US
MOLLARD; Paul - San Jose CA
Mollard, Paul - Cupertino CA
Mollard; Paul - Domene FR
Mollard; Paul - Sainte Foy les Lyon FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymorphic And Amorphous Forms Of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- Utanamide App 20220265578 - Mollard; Paul ; et al.	2022-08-25
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione For Suppressing And Treating Alpha-synucleinopathies, Tauopathies, And Other Disorders App 20220220054 - Hinman; Andrew W. ; et al.	2022-07-14
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Grant 11,304,914 - Mollard , et al. April 19, 2	2022-04-19
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione For Suppressing And Treating Alpha-synucleinopathies, Tauopathies, And Other Disorders App 20220106248A1 -	2022-04-07
Methods For Enriching Alpha-tocotrienol From Mixed Tocol Compositions App 20220048880 - GIANNOUSIS; Peter ; et al.	2022-02-17
Methods for enriching alpha-tocotrienol from mixed tocol compositions Grant 11,186,559 - Giannousis , et al. November 30, 2	2021-11-30
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders Grant 11,174,212 - Hinman , et al. November 16, 2	2021-11-16
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione For Suppressing And Treating Alpha-synucleinopathies, Tauopathies, And Other Disorders App 20210276937 - Hinman; Andrew W. ; et al.	2021-09-09
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20210179542 - JANKOWSKI; Orion D. ; et al.	2021-06-17
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 10,968,166 - Jankowski , et al. April 6, 2	2021-04-06
Polymorphic And Amorphous Forms Of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- Utanamide App 20210015765 - MOLLARD; Paul ; et al.	2021-01-21
Methods For Enriching Alpha-tocotrienol From Mixed Tocol Compositions App 20200377468 - GIANNOUSIS; Peter ; et al.	2020-12-03
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Grant 10,751,302 - Mollard , et al. A	2020-08-25
Methods for enriching alpha-tocotrienol from mixed tocol compositions Grant 10,745,371 - Giannousis , et al. A	2020-08-18
Polymorphic And Amorphous Forms Of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- Utanamide App 20190307706 - MOLLARD; Paul ; et al.	2019-10-10
4-(p-quinonyl)-2-hydroxybutanamide Derivatives For Treatment Of Mitochondrial Diseases App 20190270699 - Jankowski; Orion D. ; et al.	2019-09-05
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Grant 10,251,847 - Mollard , et al.	2019-04-09
Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols Grant 10,202,325 - Mollard Feb	2019-02-12
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 10,167,251 - Jankowski , et al. J	2019-01-01
Improved Methods For Enriching Alpha-tocotrienol From Mixed Tocol Compositions App 20180362492 - GIANNOUSIS; Peter ; et al.	2018-12-20
Methods For Selective Oxidation Of Alpha Tocotrienol In The Presence Of Non-alpha Tocotrienols App 20180319730 - MOLLARD; Paul	2018-11-08
Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols Grant 10,029,971 - Mollard July 24, 2	2018-07-24
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,932,286 - Miller , et al. April 3, 2	2018-04-03
Polymorphic And Amorphous Forms Of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- Utanamide App 20180000749 - MOLLARD; Paul ; et al.	2018-01-04
Methods For Chiral Resolution Of Trolox App 20180002247 - MOLLARD; Paul ; et al.	2018-01-04
4-(pQUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20170313649 - JANKOWSKI; Orion D. ; et al.	2017-11-02
Methods For Selective Oxidation Of Alpha Tocotrienol In The Presence Of Non-alpha Tocotrienols App 20170297991 - Mollard; Paul	2017-10-19
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols Grant 9,567,279 - Mollard February 14, 2	2017-02-14
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 9,546,132 - Jankowski , et al. January 17, 2	2017-01-17
Catechol derivatives for treatment of oxidative stress diseases Grant 9,464,016 - Mollard , et al. October 11, 2	2016-10-11
Side-chain Variants Of Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20160244392 - Miller; Guy M. ; et al.	2016-08-25
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20160075638 - JANKOWSKI; Orion D. ; et al.	2016-03-17
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,278,085 - Miller , et al. March 8, 2	2016-03-08
Methods For Selective Oxidation Of Alpha Tocotrienol In The Presence Of Non-alpha Tocotrienols App 20160002138 - Mollard; Paul	2016-01-07
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 9,169,196 - Jankowski , et al. October 27, 2	2015-10-27
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols Grant 9,162,957 - Mollard October 20, 2	2015-10-20
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES App 20140329860 - Hinman; Andrew W. ; et al.	2014-11-06
Methods For Selective Oxidation Of Alpha Tocotrienol In The Presence Of Non-alpha Tocotrienols App 20140249332 - Mollard; Paul	2014-09-04
Catechol Derivatives For Treatment Of Oxidative Stress Diseases App 20140243424 - Mollard; Paul ; et al.	2014-08-28
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Grant 8,716,527 - Hinman , et al. May 6, 2	2014-05-06
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20130289034 - JANKOWSKI; Orion D. ; et al.	2013-10-31
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 8,519,001 - Jankowski , et al. August 27, 2	2013-08-27
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20120122934 - Jankowski; Orion D. ; et al.	2012-05-17
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Grant 7,968,746 - Jankowski , et al. June 28, 2	2011-06-28
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES App 20110124679 - Hinman; Andrew W. ; et al.	2011-05-26
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES App 20090118257 - Jankowski; Orion D. ; et al.	2009-05-07
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20070225261 - Miller; Guy M. ; et al.	2007-09-27
Practical, cost-effective synthesis of CoQ10 App 20050137410 - Lipshutz, Bruce H. ; et al.	2005-06-23
Practical, cost-effective synthesis of CoQ10 Grant 6,852,895 - Lipshutz , et al. February 8, 2	2005-02-08
Practical, cost-effective synthesis of CoQ10 App 20030073869 - Lipshutz, Bruce H. ; et al.	2003-04-17
Treatment of pulverant magnetic materials and products thus obtained Grant 5,580,396 - Fruchart , et al. December 3, 1	1996-12-03
Process for the production of sodium percarbonate Grant 4,022,874 - Mollard , et al. May 10, 1	1977-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.